International Journal of Gynecological Cancer,
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemo and #BEV compared w…
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in…
Overview of attention for article published in International Journal of Gynecological Cancer, September 2023
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (82nd percentile)
-
Good Attention Score compared to outputs of the same age and source (77th percentile)
Readers on
- mendeley
- 18 Mendeley